Cryo-Cell International Inc
CCEL3.750USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
30.21MMarket Cap
LossP/E TTM
More Details of Cryo-Cell International Inc Company
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Cryo-Cell International Inc Info
Ticker SymbolCCEL
Company nameCryo-Cell International Inc
IPO dateApr 04, 1994
CEOPortnoy (Mark L)
Number of employees82
Security typeOrdinary Share
Fiscal year-endApr 04
Address700 Brooker Creek Blvd
CityOLDSMAR
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code34677
Phone18137492104
Websitehttps://www.cryo-cell.com/
Ticker SymbolCCEL
IPO dateApr 04, 1994
CEOPortnoy (Mark L)
Company Executives of Cryo-Cell International Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.93%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.93%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Processing and storage fees
7.87M
99.28%
Public banking revenue
42.69K
0.54%
Product revenue
14.44K
0.18%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Processing and storage fees
7.87M
99.28%
Public banking revenue
42.69K
0.54%
Product revenue
14.44K
0.18%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Portnoy (David I)
21.08%
Portnoy (Mark)
11.62%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
53.84%
Shareholders
Shareholders
Proportion
Portnoy (David I)
21.08%
Portnoy (Mark)
11.62%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
53.84%
Shareholder Types
Shareholders
Proportion
Individual Investor
41.98%
Investment Advisor
6.16%
Private Equity
5.09%
Investment Advisor/Hedge Fund
0.74%
Hedge Fund
0.28%
Other
45.74%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
34
988.98K
13.06%
--
2025Q3
35
988.98K
13.05%
-7.47K
2025Q2
32
996.45K
12.94%
-34.34K
2025Q1
31
1.03M
12.77%
-1.40K
2024Q4
28
1.03M
13.60%
+129.95K
2024Q3
23
901.35K
13.54%
+4.71K
2024Q2
24
896.63K
13.23%
+22.67K
2024Q1
26
873.96K
13.34%
-231.88K
2023Q4
28
864.43K
13.53%
+21.68K
2023Q3
26
862.32K
13.61%
+13.39K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Portnoy (David I)
1.68M
20.81%
+107.02K
+6.81%
Sep 18, 2025
Portnoy (Mark)
935.77K
11.61%
--
--
Sep 15, 2025
Fleishman (Adam)
509.00K
6.31%
--
--
Sep 15, 2025
Hamilton Lane Advisors, LLC
409.73K
5.08%
--
--
Sep 30, 2025
SFI Advisors LLC
165.30K
2.05%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
129.81K
1.61%
+11.58K
+9.79%
Jun 30, 2025
The MassMutual Trust Company, FSB
111.03K
1.38%
--
--
Jun 30, 2025
Mikulinsky (Oleg)
104.35K
1.29%
--
--
Sep 15, 2025
Berger (Harold D)
57.90K
0.72%
--
--
Sep 15, 2025
Geode Capital Management, L.L.C.
45.83K
0.57%
+601.00
+1.33%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
9.69M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
May 08, 2025
CCEL.NB Interim Cash Dividend of gross USD 0.15 paid on May 30, 2025 going ex on May 21, 2025
May 21, 2025
May 30, 2025
May 21, 2025
Jan 29, 2025
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Feb 28, 2025
Feb 14, 2025
Oct 31, 2024
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Cryo-Cell International Inc?
The top five shareholders of Cryo-Cell International Inc are:
Portnoy (David I) holds 1.68M shares, accounting for 20.81% of the total shares.
Portnoy (Mark) holds 935.77K shares, accounting for 11.61% of the total shares.
Fleishman (Adam) holds 509.00K shares, accounting for 6.31% of the total shares.
Hamilton Lane Advisors, LLC holds 409.73K shares, accounting for 5.08% of the total shares.
SFI Advisors LLC holds 165.30K shares, accounting for 2.05% of the total shares.
Portnoy (David I) holds 1.68M shares, accounting for 20.81% of the total shares.
Portnoy (Mark) holds 935.77K shares, accounting for 11.61% of the total shares.
Fleishman (Adam) holds 509.00K shares, accounting for 6.31% of the total shares.
Hamilton Lane Advisors, LLC holds 409.73K shares, accounting for 5.08% of the total shares.
SFI Advisors LLC holds 165.30K shares, accounting for 2.05% of the total shares.
What are the top three shareholder types of Cryo-Cell International Inc?
The top three shareholder types of Cryo-Cell International Inc are:
Portnoy (David I)
Portnoy (Mark)
Fleishman (Adam)
Portnoy (David I)
Portnoy (Mark)
Fleishman (Adam)
How many institutions hold shares of Cryo-Cell International Inc (CCEL)?
As of 2025Q4, 34 institutions hold shares of Cryo-Cell International Inc, with a combined market value of approximately 988.98K, accounting for 13.06% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.01%.
What is the biggest source of revenue for Cryo-Cell International Inc?
In FY2025Q2, the Processing and storage fees business generated the highest revenue for Cryo-Cell International Inc, amounting to 7.87M and accounting for 99.28% of total revenue.
